Company Filing History:
Years Active: 2014
Title: Revolutionary Innovations by Stephen L. Jones in Immunology
Introduction
Stephen L. Jones, an accomplished inventor based in East Brunswick, Australia, has made significant contributions to the field of immunology. His inventive spirit and dedication to enhancing medical testing have led to the development of a notable patent that facilitates rapid and efficient immune response assessment.
Latest Patents
Stephen L. Jones holds a patent for a breakthrough invention titled "Cell-mediated immune response assay and kits therefor." This innovative method provides a means to measure cell-mediated immune responses using small volumes of whole, undiluted blood collected from a subject. The methods allow for testing blood samples ranging from 50 µl to 500 µl, making it possible for rapid testing across various demographics, including pediatric, adult, and geriatric patients.
Career Highlights
Throughout his career, Stephen has been integral to Cellestis Limited, a company dedicated to advancing diagnostic technologies. His work has highlighted the importance of accessibility in medical testing, particularly in evaluating immune responses without the need for large blood samples.
Collaborations
Stephen has collaborated with esteemed colleagues Anthony J. Radford and Jenny Louise Howard. Together, they combine their expertise to enhance the development of innovative medical solutions and improve patient outcomes through advanced diagnostic methods.
Conclusion
In conclusion, Stephen L. Jones exemplifies the spirit of innovation within the realm of immunology. His patent on cell-mediated immune response assays not only addresses critical testing needs but also sets a precedent for future developments in medical diagnostics. His contributions continue to pave the way for significant advancements in healthcare and patient care.